BY THE NUMBERS.

The ABF Journal's "BY THE NUMBERS" article from Q3 2024 presents key data points in an infographic format. Some highlights include the Freightos' Baltic Index surpassing $5K for the first time since Sept. 2022, the funding required for a phase 2 biotech trial ranging from $10MM to $100MM, and the establishment of the Uniform Commercial Code in 1952. Additionally, the article mentions the percentages of drugs moving from phase 1 to phase 2 trials, the passing of the Glass-Steagall Act in 1933, and the SBA reimbursing lenders up to a certain percentage of loss amount in its programs. [Extracted from the article]